Shanhe Wan

846 total citations
44 papers, 678 citations indexed

About

Shanhe Wan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Shanhe Wan has authored 44 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Shanhe Wan's work include Cancer therapeutics and mechanisms (13 papers), Quinazolinone synthesis and applications (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Shanhe Wan is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Quinazolinone synthesis and applications (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Shanhe Wan collaborates with scholars based in China, Russia and Singapore. Shanhe Wan's co-authors include Jiajie Zhang, Xiaoyun Wu, Zhonghuang Li, P.Y. Yu, Yuanxin Tian, Dong-Mei Meng, Qing Wen, Xiaohong Chen, Qingbing Zeng and Yuegang Wang and has published in prestigious journals such as ACS Nano, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Shanhe Wan

41 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanhe Wan China 16 337 172 122 107 57 44 678
Mohammad Sarwar Jamal Saudi Arabia 19 467 1.4× 71 0.4× 203 1.7× 86 0.8× 18 0.3× 37 992
David Vásquez Chile 15 275 0.8× 232 1.3× 169 1.4× 65 0.6× 17 0.3× 36 750
Hongjiang Xu China 15 373 1.1× 192 1.1× 106 0.9× 41 0.4× 13 0.2× 41 773
Christopher W. Carreras United States 17 1.1k 3.3× 142 0.8× 309 2.5× 92 0.9× 30 0.5× 35 1.5k
Linlin Chang China 17 606 1.8× 77 0.4× 134 1.1× 65 0.6× 22 0.4× 48 1.0k
N. Handa Japan 19 942 2.8× 81 0.5× 102 0.8× 83 0.8× 14 0.2× 30 1.2k
Antonio Artigues United States 23 767 2.3× 88 0.5× 54 0.4× 34 0.3× 40 0.7× 60 1.2k
Chuanfang Wu China 19 884 2.6× 92 0.5× 101 0.8× 208 1.9× 12 0.2× 59 1.3k
Nathalie Dias France 15 998 3.0× 317 1.8× 106 0.9× 51 0.5× 33 0.6× 19 1.4k
Abdel Khalig Muddathir Sudan 7 553 1.6× 68 0.4× 210 1.7× 75 0.7× 10 0.2× 12 946

Countries citing papers authored by Shanhe Wan

Since Specialization
Citations

This map shows the geographic impact of Shanhe Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanhe Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanhe Wan more than expected).

Fields of papers citing papers by Shanhe Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanhe Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanhe Wan. The network helps show where Shanhe Wan may publish in the future.

Co-authorship network of co-authors of Shanhe Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Shanhe Wan. A scholar is included among the top collaborators of Shanhe Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanhe Wan. Shanhe Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaotian, Qian Guo, Shanhe Wan, et al.. (2025). Design and synthesis of Betti base derivatives as EGFR inhibitors. Bioorganic Chemistry. 164. 108872–108872.
2.
Zhao, Zean, Xinhua Chen, Jiajun Luo, et al.. (2024). Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents. European Journal of Medicinal Chemistry. 277. 116753–116753. 3 indexed citations
3.
4.
Wang, Shuyi, Xiaotian Xu, Qian Guo, et al.. (2024). Identification of New EGFR Inhibitors by Structure-Based Virtual Screening and Biological Evaluation. International Journal of Molecular Sciences. 25(3). 1887–1887. 6 indexed citations
5.
Jiang, Ying, Chunhui Huang, Guowu Wu, et al.. (2023). A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma. Pharmaceutics. 15(5). 1501–1501. 5 indexed citations
6.
Luo, Jiajun, Xinhua Chen, Zean Zhao, et al.. (2023). Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking. Computers in Biology and Medicine. 155. 106637–106637. 16 indexed citations
7.
Liang, Junyu, Xiaodong Tang, Shanhe Wan, et al.. (2023). Structure Modification of Ginsenoside Rh2 and Cytostatic Activity on Cancer Cells. ACS Omega. 8(19). 17245–17253. 3 indexed citations
8.
Liu, Siming, Chuan Huang, Chunhui Huang, et al.. (2023). Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1 G2032R and ALK G1202R. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2227779–2227779. 6 indexed citations
9.
Guo, Qian, Shuyi Wang, Shanhe Wan, et al.. (2022). Design and synthesis of proteolysis targeting chimeras (PROTACs) as an EGFR degrader based on CO-1686. European Journal of Medicinal Chemistry. 238. 114455–114455. 22 indexed citations
10.
Chen, Xinhua, Zean Zhao, Jiajun Luo, et al.. (2021). Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation. Bioorganic Chemistry. 117. 105444–105444. 16 indexed citations
11.
Yang, Zichao, Hai‐Kui Yang, Zhonghuang Li, et al.. (2020). Computational studies of potent covalent inhibitors on wild type or T790M/L858R mutant epidermal growth factor receptor. European Journal of Pharmaceutical Sciences. 152. 105463–105463. 11 indexed citations
12.
Jiang, Ying, Zichao Yang, Siming Liu, et al.. (2020). The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 188. 113400–113400. 2 indexed citations
13.
Liu, Siming, Ying Jiang, Zhonghuang Li, et al.. (2019). Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors. European Journal of Medicinal Chemistry. 179. 358–375. 26 indexed citations
14.
Tian, Yuanxin, Tingting Zhang, Zhonghuang Li, et al.. (2017). Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors. European Journal of Medicinal Chemistry. 143. 182–199. 13 indexed citations
15.
Tian, Yuanxin, Yu‐Dong Shen, Shan Chang, et al.. (2017). Molecular Simulation Studies on the Binding Selectivity of Type-I Inhibitors in the Complexes with ROS1 versus ALK. Journal of Chemical Information and Modeling. 57(4). 977–987. 16 indexed citations
16.
17.
Meng, Dong-Mei, Hong Wang, Shanhe Wan, et al.. (2017). Preventive and Therapeutic Effects of Thymol in a Lipopolysaccharide-Induced Acute Lung Injury Mice Model. Inflammation. 41(1). 183–192. 47 indexed citations
18.
Wan, Shanhe, et al.. (2016). Anti-inflammatory and Anti-oxidative Effects of Dexpanthenol on Lipopolysaccharide Induced Acute Lung Injury in Mice. Inflammation. 39(5). 1757–1763. 49 indexed citations
19.
Wu, Xiaoyun, Shanhe Wan, Hong Jin, et al.. (2014). Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2. Journal of Molecular Graphics and Modelling. 56. 103–112. 21 indexed citations
20.
Liang, Li‐Li, et al.. (2010). Rapid UPLC–MS/MS method for the determination of sufentanil in human plasma and its application in target-controlled infusion system. Journal of Pharmaceutical and Biomedical Analysis. 54(4). 838–844. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Sarwar Jamal Breakdown of academic impact, for papers by David Vásquez Breakdown of academic impact, for papers by Hongjiang Xu Breakdown of academic impact, for papers by Christopher W. Carreras Breakdown of academic impact, for papers by Linlin Chang Breakdown of academic impact, for papers by N. Handa Breakdown of academic impact, for papers by Antonio Artigues Breakdown of academic impact, for papers by Chuanfang Wu Breakdown of academic impact, for papers by Nathalie Dias Breakdown of academic impact, for papers by Abdel Khalig Muddathir
Rankless by CCL
2026